NCI OUTSTANDING INVESTIGATOR AWARD 

NIH GUIDE, Volume 21, Number 14, April 10, 1992

 

P.T. 34



Keywords:

  Grants Administration/Policy+ 

 

National Cancer Institute

 

In order to be able to meet NIH cost containment objectives (NIH

Guide, Vol. 20, No. 28, July 19, 1991), the National Cancer Institute

is currently  reviewing options for revision of the guidelines and

purposes of its Outstanding Investigator Grant (OIG) (R35) program.

To reduce additional commitments during this period of evaluation,

new type 1 applications will not be accepted for the previously

announced June 1, 1992, receipt deadline.  In the interim, NCI will

rely on careful consideration of highly meritorious competing R01

applications for funding as MERIT awards to provide longer term

support for individual projects of exceptional potential.

 

To avoid disruption of ongoing OIG awards, competing continuation

applications (type 2) for OIG grants that currently are in the fifth

(05) year or later will continue to be accepted and may be submitted

by June 1, 1992.

 

Future receipt dates and a notice of availability of revised OIG

guidelines will be published subsequently in the NIH Guide.

 

For additional information or for questions concerning this notice,

contact:

 

Mrs. Barbara S. Bynum

Director, Division of Extramural Activities

National Cancer Institute

Building 31, Room 10A03

Bethesda, MD  20892

Telephone:  (301) 496-5147

FAX:  (301) 402-0062

 

.

Return to 1992 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.